SCHEMBL174759

SCHEMBL174759

O=C1N=CC=NC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4504815 0.75
SCHEMBL72400 0.73
SCHEMBL3870589 0.70
SCHEMBL14830653 0.69
SCHEMBL14830503 0.69
SCHEMBL867457 0.69
SCHEMBL14829308 0.69
SCHEMBL7569561 0.66
SCHEMBL7409317 0.66
SCHEMBL336074 0.65

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 91 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119285640-A Naphthalene dione pyrazine fused ring compound and preparation method and application thereof 西京学院 2025-01-10 CN claimed
EP-4204413-B1 DIHYDROQUINAZOLIN-2-ONE DERIVATIVES AS SELECTIVE CYTOTOXIC AGENTS USEFUL IN THE TREATMENT OF HIV MERCK SHARP & DOHME LLC (US) 2024-09-25 EP claimed
CN-116745269-A Dihydroquinazolin-2-one derivatives as selective cytotoxic agents for the treatment of HIV 默沙东有限责任公司 2023-09-12 CN claimed
CN-114920930-A Pyrazine-benzoquinone structure-containing polymer and application thereof in lithium ion/water-based zinc ion battery 安徽大学 2022-08-19 CN claimed
CN-107686483-B Heptacyclic acetals, their preparation, antithrombotic activity and use 首都医科大学 2020-01-14 CN claimed
EP-2174934-B1 OXOPYRAZINE DERIVATIVE AND HERBICIDE KUMIAI CHEMICAL INDUSTRY CO (JP) 2012-06-06 EP claimed
JP-2002539162-A 2002-11-19 JP claimed
EP-1161238-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST Aventis Pharma S.A. (FR) 2001-12-12 EP claimed
WO-2000054772-A1 AMYOTROPIC LATERAL SCLEROSIS TREATMENT WITH A COMBINATION OF RILUZOLE AND AN AMPA RECEPTOR ANTAGONIST AVENTIS PHARMA S.A. (FR) 2000-09-21 WO claimed
EP-4574207-A2 MEANS AND METHODS FOR TREATING COPPER-RELATED DISEASES Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) (DE) 2025-06-25 EP disclosed
CN-119859151-A Alkaloid compound separated from rhizoma smilacis glabrae and preparation method and application thereof 北京振东光明药物研究院有限公司 2025-04-22 CN disclosed
CN-119409834-A Methods and compositions for promoting and enhancing T cell mediated immune responses through ADCC targeting of CD39 expressing cells 北京恩瑞尼生物科技股份有限公司 2025-02-11 CN disclosed
CN-119285640-A Naphthalene dione pyrazine fused ring compound and preparation method and application thereof 西京学院 2025-01-10 CN disclosed
WO-2024192335-A1 ALTERNATIVE STRATEGIES FOR METHANOBACTIN PRODUCTION THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2024-09-19 WO disclosed
EP-0927171-A1 PYRAZINONES AND TRIAZINONES AND THEIR DERIVATIVES THEREOF Du Pont Pharmaceuticals Company (US) 1999-07-07 EP disclosed
WO-1998011075-A1 PYRAZINONES AND TRIAZINONES AND THEIR DERIVATIVES THEREOF DU PONT PHARMACEUTICALS COMPANY (US) 1998-03-19 WO disclosed
EP-0457817-A1 OXODIAMINOCYCLOTRIPHOSPHAZENE COMPOUNDS, THEIR PREPARATION AND THEIR APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 1991-11-27 EP disclosed
WO-1991008212-A1 MONO-BINO AND DI-BINO OXODIAMINODICYCLOPHOSPHAZENE DERIVATIVES CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1991-06-13 WO disclosed
EP-0402096-A2 Anticonvulsant pyrazines THE WELLCOME FOUNDATION LIMITED (GB) 1990-12-12 EP disclosed
WO-1990009390-A1 OXODIAMINOCYCLOTRIPHOSPHAZENE COMPOUNDS, THEIR PREPARATION AND THEIR APPLICATIONS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1990-08-23 WO disclosed